BioNTech SE

ISIN US09075V1026

WKN A2PSR2

Market cap (in EUR)

19,971 m

Country

Germany

Sector

Healthcare

Dividend yield

0.00%

Overview

Quote

Description

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Show more Show less

Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals Germany

Chart

Financials

Key metrics

Market capitalisation, EUR	19,971 m
EPS, EUR	-5.07
P/B ratio	1.1
P/E ratio	159.5
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	2,871 m
Net income, EUR	-1,137 m
Profit margin	-39.59%

What ETF is BioNTech SE in?

There are 43 ETFs which contain BioNTech SE. All of these ETFs are listed in the table below. The ETF with the largest weighting of BioNTech SE is the VanEck Genomics and Healthcare Innovators UCITS ETF A.

ETF	Weight	Investment focus	Fund size (in m EUR)
Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D)	0.14%	Equity World Health Care Social/Environmental	125
Amundi Prime Global UCITS ETF Acc	0.01%	Equity World	2,786
WisdomTree BioRevolution UCITS ETF USD Acc	0.99%	Equity World Health Care Social/Environmental Biotech	20
Amundi Prime Global UCITS ETF Dist	0.01%	Equity World	1,591
Invesco RAFI All-World Fundamental Value UCITS ETF	0.04%	Equity World Value	238
iShares World Equity Enhanced Active UCITS ETF EUR Hedged (Acc)	0.02%	Equity World Social/Environmental Multi-Asset Strategy	132
Franklin S&P World Screened UCITS ETF Acc	0.01%	Equity United States Social/Environmental Climate Change	13
Amundi F.A.Z. 100 UCITS ETF Dist	0.98%	Equity Germany	101
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing	0.04%	Equity World Multi-Factor Strategy	217
Xtrackers EMU Net Zero Pathway Paris Aligned UCITS ETF 1C	0.56%	Equity Europe Social/Environmental Climate Change	9
UBS Climate Aware Global Developed Equity CTB UCITS ETF USD acc	0.02%	Equity World Social/Environmental Climate Change	17
iShares World Equity Enhanced Active UCITS ETF USD (Acc)	0.02%	Equity World Social/Environmental Multi-Asset Strategy	1,747
Amundi Prime All Country World UCITS ETF Acc	0.01%	Equity World	2,326
L&G Global Equity UCITS ETF	0.01%	Equity World Social/Environmental	1,495
Xtrackers S&P Europe ex UK UCITS ETF	0.08%	Equity Europe	288
iShares World Equity Enhanced Active UCITS ETF GBP Hedged (Acc)	0.02%	Equity World Social/Environmental Multi-Asset Strategy	55
iShares STOXX Europe Equity Multifactor UCITS ETF EUR (Acc)	0.03%	Equity Europe Multi-Factor Strategy	597
Amundi Prime All Country World UCITS ETF Dist	0.01%	Equity World	4,614
Invesco S&P World Health Care ESG UCITS ETF	0.22%	Equity World Health Care Social/Environmental	9
WisdomTree Megatrends UCITS ETF USD	0.15%	Equity World Social/Environmental Innovation	58
Xtrackers World Biodiversity Focus SRI UCITS ETF 1C	0.02%	Equity World Social/Environmental	17
VanEck Genomics and Healthcare Innovators UCITS ETF A	4.97%	Equity World Health Care Social/Environmental Innovation	12
Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF 1C	0.04%	Equity World Social/Environmental Climate Change	122
ARK Genomic Revolution UCITS ETF USD Accumulating	1.20%	Equity World Health Care Innovation	74
Global X Genomics & Biotechnology UCITS ETF	3.41%	Equity World Health Care Biotech	46
iShares Dow Jones Global Leaders Screened UCITS ETF USD (Acc)	0.04%	Equity World Social/Environmental	1,823
Amundi S&P Eurozone Climate Paris Aligned UCITS ETF Dist	0.13%	Equity Europe Social/Environmental Climate Change	365
First Trust NYSE Arca Biotechnology UCITS ETF Acc	3.01%	Equity United States Health Care Biotech	12
Invesco Nasdaq Next Generation 100 UCITS ETF Acc	0.50%	Equity United States	46
Amundi Prime Europe UCITS ETF DR (D)	0.07%	Equity Europe	252
iShares STOXX Europe Equity Multifactor UCITS ETF EUR (Dist)	0.03%	Equity Europe Multi-Factor Strategy	205
Franklin Future Of Health And Wellness UCITS ETF	0.93%	Equity World Health Care Social/Environmental	3
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.87%	Equity United States Health Care Biotech	64
Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A)	0.14%	Equity World Health Care Social/Environmental	880
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating	0.04%	Equity World Multi-Factor Strategy	1,340
iShares Nasdaq US Biotechnology UCITS ETF	0.87%	Equity United States Health Care Biotech	958
Amundi S&P Eurozone Climate Paris Aligned UCITS ETF Acc	0.13%	Equity Europe Social/Environmental Climate Change	2,728
L&G Europe ex UK Equity UCITS ETF	0.10%	Equity Europe Social/Environmental	471
Amundi Prime Eurozone UCITS ETF DR (C)	0.14%	Equity Europe	103
Amundi Prime Eurozone UCITS ETF DR (D)	0.14%	Equity Europe	79
WisdomTree Tech Megatrends UCITS ETF USD Acc	0.37%	Equity World Technology Social/Environmental Innovation	8
Xtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF 1C	0.21%	Equity Europe Social/Environmental Climate Change	7
Amundi Prime Europe UCITS ETF DR (C)	0.07%	Equity Europe	226

Performance

Returns overview

YTD	-4.74%
1 month	-0.07%
3 months	-5.89%
6 months	-15.60%
1 year	-19.40%
3 years	-19.39%
5 years	-55.35%
Since inception (MAX)	+500.71%
2025	-21.19%
2024	+8.67%
2023	-35.01%
2022	-29.26%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).